Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
Explore this paper's citation graph
Summary
While NAI antibody is not produced to a large extent in response to current IIV, it appears to have an independent role in protection, and as new influenza vaccines are developed, NA content should be considered.
- Type
- article
- Published
- 2015-10-15
- Cited by
- 330
- References
- 22
- Access
- Open access
- OpenAlex
- https://openalex.org/W2164759517
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38752172
Keywords
Neuraminidase, Virology, Titer, Hemagglutination assay, Hemagglutinin (influenza)
References
- Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
- Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
- Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
- Determinants of immunity to influenza infection in man.
- A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigens
- Effect of neuraminidase antibody on Hong Kong influenza.
- The influenza vaccine licensing process.
- Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.
- Stability of neuraminidase in inactivated influenza vaccines.
- Randomized Comparative Study of the Serum Antihemagglutinin and Antineuraminidase Antibody Responses to Six Licensed Trivalent Influenza Vaccines
- An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera.
- Comparative efficacy of inactivated and live attenuated influenza vaccines.
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
- Influenza viral neuraminidase: the forgotten antigen
- Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
- Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
- Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays
- Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
- Immunological assessment of influenza vaccines and immune correlates of protection
- Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures.
Cited by
- AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
- Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines
- Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays
- Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
- Neuraminidase: Another Piece of the Influenza Vaccine Puzzle.
- An influenza vaccine pill-can we swallow it?
- Prospects for Broadly Protective Influenza Vaccines.
- Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.
- Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
- Pathogenicity and transmissibility of novel influenza viruses
- Influenza immunology evaluation and correlates of protection: a focus on vaccines
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
- Systems immunology: Beyond antibody titers.
- Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
- The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus
- Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population.
- Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
- A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
- Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
Related papers
- Hemagglutination assay and hemagglutination inhibition assay of the canine influenza virus subtype H3N2.
- Comparison of hemagglutination inhibition and hemagglutinin pseudovirus neutralization titres in relation to protection against influenza in a mouse model
- Attempts to demonstrate hemagglutination and hemadsorption by respiratory syncytial virus.
- [Specific and non-specific reaction of hemagglutination for the detection of anti-thyroglobulin antibody (author's transl)].
- Hemagglutination and Hemagglutination-Inhibition with Adenovirus Type 12.∗
- The relation between the infectivity and the hemagglutinin of murine encephalomyelitis virus (GDVII).
- Determination of immune status in patients with low antibody titers for rubella virus
- An improved method for hemagglutinin extraction from feline herpesvirus type 1-infected cell line.